The pharma industry's dreaded patent cliff is a key driver of the stock's decline.

Fintel reports that on February 20, 2026, Barclays initiated coverage of Bristol-Myers Squibb (NYSE:BMY) with a Overweight ...

Bristol-Myers Squibb Company (NYSE:BMY) is one of the best medical research stocks to buy according to hedge funds. Bernstein reiterated its Hold rating on Bristol-Myers Squibb Company (NYSE:BMY) on ...

Bristol-Myers Squibb Company hits a 52-week high as Breyanzi sales surge and AI imaging expands. Click for this updated look at BMY stock prospects.

Bristol-Myers Squibb (NYSE:BMY) has outlined a broad pipeline refresh that includes multiple recent product launches and the announcement of a new R&D facility. The company has agreed to acquire ...

June Squibb opens up about starring in Broadway’s ‘Marjorie Prime’ at 96, her life in New York in her 20s, and why acting ...

Bristol Myers stock is volatile ahead of earnings as investors weighed its expanded OXB manufacturing deal and recent bullish analyst commentary.

OXB to become commercial manufacturer of lentiviral vectors for Bristol Myers Squibb (BMS) CAR-T programmesMulti-year agreement with five-year ...

FDA has accepted the NDA for BMS's Iberdomide, an oral agent targetting relapsed/refractory multiple myeloma.

Read full article: Defense to call fourth witness to stand on Day 18 in trial of ex-officers charged in Melissa Perez’s death TORONTO, ONT – There are 70-year-olds who want to be like June Squibb when ...